215 related articles for article (PubMed ID: 34304557)
1. Δ
Schafroth MA; Mazzoccanti G; Reynoso-Moreno I; Erni R; Pollastro F; Caprioglio D; Botta B; Allegrone G; Grassi G; Chicca A; Gasparrini F; Gertsch J; Carreira EM; Appendino G
J Nat Prod; 2021 Sep; 84(9):2502-2510. PubMed ID: 34304557
[TBL] [Abstract][Full Text] [Related]
2. Cis-Δ
Tolomeo F; Russo F; Kaczorova D; Vandelli MA; Biagini G; Laganà A; Capriotti AL; Paris R; Fulvio F; Carbone L; Perrone E; Gigli G; Cannazza G; Citti C
J Pharm Biomed Anal; 2022 Sep; 219():114958. PubMed ID: 35930832
[TBL] [Abstract][Full Text] [Related]
3. Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal
Linciano P; Citti C; Luongo L; Belardo C; Maione S; Vandelli MA; Forni F; Gigli G; Laganà A; Montone CM; Cannazza G
J Nat Prod; 2020 Jan; 83(1):88-98. PubMed ID: 31891265
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor.
Fischedick J; Van Der Kooy F; Verpoorte R
Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):201-7. PubMed ID: 20118579
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.
DeLong GT; Wolf CE; Poklis A; Lichtman AH
Drug Alcohol Depend; 2010 Nov; 112(1-2):126-33. PubMed ID: 20619971
[TBL] [Abstract][Full Text] [Related]
6. Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol.
Linciano P; Citti C; Russo F; Tolomeo F; Laganà A; Capriotti AL; Luongo L; Iannotta M; Belardo C; Maione S; Forni F; Vandelli MA; Gigli G; Cannazza G
Sci Rep; 2020 Dec; 10(1):22019. PubMed ID: 33328530
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
El-Alfy AT; Ivey K; Robinson K; Ahmed S; Radwan M; Slade D; Khan I; ElSohly M; Ross S
Pharmacol Biochem Behav; 2010 Jun; 95(4):434-42. PubMed ID: 20332000
[TBL] [Abstract][Full Text] [Related]
8. Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol.
Abdel-Kader MS; Radwan MM; Metwaly AM; Eissa IH; Hazekamp A; ElSohly MA
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542886
[No Abstract] [Full Text] [Related]
9. A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ
Citti C; Linciano P; Russo F; Luongo L; Iannotta M; Maione S; Laganà A; Capriotti AL; Forni F; Vandelli MA; Gigli G; Cannazza G
Sci Rep; 2019 Dec; 9(1):20335. PubMed ID: 31889124
[TBL] [Abstract][Full Text] [Related]
10. Uncovering the psychoactivity of a cannabinoid from liverworts associated with a legal high.
Chicca A; Schafroth MA; Reynoso-Moreno I; Erni R; Petrucci V; Carreira EM; Gertsch J
Sci Adv; 2018 Oct; 4(10):eaat2166. PubMed ID: 30397641
[TBL] [Abstract][Full Text] [Related]
11. Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys.
Hruba L; Ginsburg BC; McMahon LR
J Pharmacol Exp Ther; 2012 Sep; 342(3):843-9. PubMed ID: 22718500
[TBL] [Abstract][Full Text] [Related]
12. Using Transformer-Based Topic Modeling to Examine Discussions of Delta-8 Tetrahydrocannabinol: Content Analysis.
Smith BP; Hoots B; DePadilla L; Roehler DR; Holland KM; Bowen DA; Sumner SA
J Med Internet Res; 2023 Dec; 25():e49469. PubMed ID: 38127427
[TBL] [Abstract][Full Text] [Related]
13. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600
[TBL] [Abstract][Full Text] [Related]
14. Phytocannabinoid Pharmacology: Medicinal Properties of
Sampson PB
J Nat Prod; 2021 Jan; 84(1):142-160. PubMed ID: 33356248
[TBL] [Abstract][Full Text] [Related]
15. Distribution of Chemical Phenotypes (Chemotypes) in European Agricultural Hemp (Cannabis sativa L.) Cultivars.
Borroto Fernandez E; Peterseil V; Hackl G; Menges S; de Meijer E; Staginnus C
J Forensic Sci; 2020 May; 65(3):715-721. PubMed ID: 31770468
[TBL] [Abstract][Full Text] [Related]
16. Delta 9-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication.
Balster RL; Prescott WR
Neurosci Biobehav Rev; 1992; 16(1):55-62. PubMed ID: 1313164
[TBL] [Abstract][Full Text] [Related]
17. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
Janoyan JJ; Crim JL; Darmani NA
Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
[TBL] [Abstract][Full Text] [Related]
18. Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB
Wang XF; Galaj E; Bi GH; Zhang C; He Y; Zhan J; Bauman MH; Gardner EL; Xi ZX
Br J Pharmacol; 2020 Apr; 177(8):1865-1880. PubMed ID: 31877572
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the impact of hemp food consumption on workplace drug tests.
Leson G; Pless P; Grotenhermen F; Kalant H; ElSohly MA
J Anal Toxicol; 2001; 25(8):691-8. PubMed ID: 11765026
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of Medical Cannabis.
Amin MR; Ali DW
Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
